Based on this study, we concluded that knocking down DR6 expression inhibits mouse B16 melanoma tumor growth by suppressing the expression of the blood vessel formation-related factors VEGF-A, PDGF-β, VEGF-D and PDGFR-α, and therefore blocks tumor angiogenesis. Here, TNFRSF21 is linked to melanoma.